Raymond K. Hau

发表

Predicting disruptions to drug pharmacokinetics and the risk of adverse drug reactions in non-alcoholic steatohepatitis patients

N. Cherrington, S. Marie, Kayla L. Frost, 2022, Acta pharmaceutica Sinica. B.

Structure-Property Relationship Studies of Influenza A Virus AM2-S31N Proton Channel Blockers.

Chunlong Ma, Jun Wang, Yanmei Hu, 2018, ACS medicinal chemistry letters.

PF‐07321332 (Nirmatrelvir) does not interact with human ENT1 or ENT2: Implications for COVID‐19 patients

S. Wright, N. Cherrington, Raymond K. Hau, 2022, Clinical and translational science.

Testicular disposition of clofarabine in rats is dependent on equilibrative nucleoside transporters

S. Wright, J. Galligan, N. Cherrington, 2021, Pharmacology research & perspectives.

Generation of a hTERT-Immortalized Human Sertoli Cell Model to Study Transporter Dynamics at the Blood-Testis Barrier

S. Wright, N. Cherrington, Siennah R. Miller, 2020, Pharmaceutics.

Predicting Drug Interactions with Human Equilibrative Nucleoside Transporters 1 and 2 Using Functional Knockout Cell Lines and Bayesian Modeling

Kimberley M. Zorn, Daniel H. Foil, S. Ekins, 2020, Molecular Pharmacology.

Nucleoside Reverse Transcriptase Inhibitor Interaction with Human Equilibrative Nucleoside Transporters 1 and 2

S. Wright, N. Cherrington, M. Morales, 2020, Drug Metabolism and Disposition.

Chemical Genomics Approach Leads to the Identification of Hesperadin, an Aurora B Kinase Inhibitor, as a Broad-Spectrum Influenza Antiviral

Chunlong Ma, Jun Wang, Yanmei Hu, 2017, International journal of molecular sciences.

Identification of NMS‐873, an allosteric and specific p97 inhibitor, as a broad antiviral against both influenza A and B viruses

Xu Zhou, Chunlong Ma, Jun Wang, 2019, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

Investigation of the Drug Resistance Mechanism of M2-S31N Channel Blockers through Biomolecular Simulations and Viral Passage Experiments.

Chunlong Ma, Jun Wang, G. Lambrinidis, 2020, ACS pharmacology & translational science.

Physiological Characterization of the Transporter-Mediated Uptake of the Reversible Male Contraceptive H2-Gamendazole Across the Blood-Testis Barrier

S. Wright, G. Georg, J. Tash, 2022, The Journal of Pharmacology and Experimental Therapeutics.

Discovery of dapivirine, a nonnucleoside HIV‐1 reverse transcriptase inhibitor, as a broad‐spectrum antiviral against both influenza A and B viruses

Chunlong Ma, Jun Wang, Yanmei Hu, 2017, Antiviral research.

Localization of Xenobiotic Transporters Expressed at the Human Blood-Testis Barrier

S. Wright, N. Cherrington, Raymond K Hau, 2022, Drug Metabolism and Disposition.

In Vitro Pharmacokinetic Optimizations of AM2-S31N Channel Blockers Led to the Discovery of Slow-Binding Inhibitors with Potent Antiviral Activity against Drug-Resistant Influenza A Viruses.

Chunlong Ma, Jun Wang, Yanmei Hu, 2018, Journal of medicinal chemistry.

Transporter Inhibition Profile for the Antivirals Tilorone, Quinacrine and Pyronaridine

Patricia A. Vignaux, S. Ekins, N. Cherrington, 2023, ACS omega.

Addressing the Clinical Importance of Equilibrative Nucleoside Transporters in Drug Discovery and Development

N. Cherrington, Raymond K. Hau, S. Wright, 2023, Clinical pharmacology and therapeutics.

Implications of Species Differences in Function and Localization of Transporters at the Blood-Testis Barrier.

N. Cherrington, Siennah R. Miller, Raymond K. Hau, 2021, Toxicological sciences : an official journal of the Society of Toxicology.